Keurig Dr Pepper

Jefferies keeps its rating on Keurig Dr Pepper at "Hold" and leaves J.M. Smucker at "Buy", even though Arabica coffee prices have risen by around 30% since June. An earthquake in Colombia is disrupting key export routes and increasing market uncertainty. Higher commodity costs could pose a headwind for the coffee companies into the first half of 2027. » More on de.investing.com

Keurig Dr Pepper has appointed Aaron Alt effective August 14, 2026, as an independent member of its board of directors and has added him to the audit and finance committee, expanding the board from nine to ten members. The company reports there are no agreements or transaction-related relationships between Alt and Keurig Dr Pepper and that he will receive the usual compensation for non-executive directors. Keurig Dr Pepper also reported Q2 results above expectations: adjusted earnings of $0.57 per share (expectation $0.54) and revenue of $7.31 billion (expectation $7.26 billion), pointing to a robust core performance despite volatile coffee prices and the integration complexity of the JDE Peet’s acquisition. » More on de.investing.com

Keurig Dr Pepper reported adjusted earnings of $0.57 per share and net revenue of $7.31 billion for the second quarter, both above analysts’ expectations. Year‑over‑year revenue growth of about 75.6% was driven largely by the integration of JDE Peet’s following the acquisition. Strong growth in the U.S. Refreshment Beverages segment and high demand for Dr Pepper and Ghost energy drinks contributed to the result. Management reaffirmed its 2026 annual revenue guidance in a range of $25.90–$26.40 billion, which is slightly below the analyst consensus and dampened the stock’s gains. » More on de.investing.com